Home > Collaborators
School of Medicine
Department of Biostatistics
- Phyllis Gimotty: Study of molecular variants of complement factor H in ovarian cancer
Department of Gastroenterology
- David Kaplan and Yonghai Li: Development of ScFv specific for human glypican-3 for adoptive T cell therapy of liver cancer
Departement of Hematology-Oncology
- Gween Danet-Desnoyers: Study of a humanized mouse model of ovarian cancer
Department of Obstetrics and Gynecology
- Center for Research on Reproduction and Women's Health (CRRWH)
- Michal A. Elovitz: Contribution of the immune response in maternal mortality from systemic illness
- George Gerton: Development of targeted nanoparticles as non-surgical sterilizing agents
- Penn Ovarian Cancer Research Center (Penn OCRC)
- George Coukos: anti-TEM1 scFv for targeted therapy and imaging; role of complement in cancer.
- Daniel J. Powell Jr.: Generation of CIRs for adoptive T cell therapy of ovarian cancer
Department of Pathology & Laboratory Medicine
- John Lambris: Role of complement in ovarian cancer.
- Don Siegel : Construction of scFv libraries
- Michael Feldman: Analysis of B cells and macrophages in ovarian cancer microarrays.
Department of Radiology
- Chatanya Divgi, Kolin Hribar and Gregory Wiedman: scFv functionalization of nanorods
- Jerry Glickson: Folate receptor, TEM1 and mesothelin targeted imaging
- Vladimir Muzykantov: radiolabeling of scFv via ester coupling of labeled tin-polymer
School of Engineering and Applied Science
Department of Material Science
- Christopher B. Murray: Development of targeted
superparamagnetic iron oxide nanoparticles (SPIONs)
2/ Extramural collaborations and/or material exchange via MTA.
Drexel Institute for Biotechnology & Virology Research, Institute for Hepatitis & Virus Research, PA
- Timothy Block and Patrick R. Romano: yeast-display libraries of lectins for generation of high affinity reagents against glycans
John Hopkins University, Baltimore, MA
- Junbiao Dai: pAGA2 and p416-BCCP plasmids to produce soluble proteins, peptides or recombinant antibodies in yeast.
Harvard University, Cambridge, MA
- David R. Liu: src kinase inhibitors
- Andrew Murray: pTOR2 and pTOR BIR bearing yeast
- Tom A. Rapoport: pTOR BIR bearing yeast
Institute for Systems Biology, Seattle WA (Past)
- Daniel Martin: Yeast-display scFv library for high-throughput identification of anti-peptides affinity reagents for SISCAPA usage
Providence Portland Medical Center, Portland, OR
- Hong-Ming Hu: Yeast-display scFv library, p416-BCCP vector and pTOR BIR bearing yeast for identification of c-type specific lectins anti-scFv
University of California, San Diego, CA
University of Georgia, Complex Carbohydrate Research Center, Athens, GA
- Karen L. Abbott and Michael Pierce: Role of GPI anchors in the tumor microenvironment and development of affinity reagents.
University of Texas, MD Anderson Cancer Center, Houston, TX
- Laurence Cooper: Yeast-display library of scFv.
University of Washington, Seattle, WA
- Andre Lieber: Desmoglein 1 study.
Vanderbuilt University, Nashville, TN
- Robert Carnahan: pAGA2 and p416-BCCP plasmids for yeast secretion, and pTOR BirA bearing yeast for production of Biobodies and coupling to sensors for quantitative analysis.
Dana Farber/Boston BioCom, Boston, MA
- Mark Poznanzki and Jeffrey Gelfand: anti-mesothelin scFv fused to tetanus toxin for targeted therapy of ovarian cancer
Amplimmune, Inc, Gaithersburg, MD
- Reagents directed against B7-H4.
Centocor, Malvern, PA
- Characterisation of a NSG-HIS mouse model of ovarian cancer.
Intelligent Optical Systems, Inc., Torrance, CA
- Srivatsa Venkatasubbarao: Biobodies for development of strip ELISAs
Lifesensors, Malvern, PA
- Tauseef Butt and Christian Loch: high yield production of biobodies in Pichia
Democritus University of Thrace, Department of Molecular Biology and Genetics, Greece.
- Raphael Sandaltzopoulos: role of GPI anchors in the tumor-microenvironment.
INSERM, Technological Advances for Genomics and Clinics (TAGC), Marseille-Luminy, France.
- Catherine Nguyen, Daniel Baty and Patrick Chames: isolation of antigen-specific scFv and nanobodies.
Universite Pierre et Marie Curie, Departement de Biochimie, Ecole de Medecine Saint-Antoine, France.
- Claude Wolf and Antonin Lamaziere: lipid analysis of tumor-released GPI anchors.
University of Queensland, Bioengineering & Nanotechnology (AIBN), Brisbane, Australia.
- Matt Trau, scFv coated: bar-coded nanoparticles for biomarker discovery.
University of Sao Paulo, Department of Clinical Medicine, Ribeirao Preto, MG, Brazil.
- Ana Maria Roselino: Desmoglein 1 study.
AbGenics, National Chemical Laboratory Innovation Park, Pune, India.
- Sanjiban Banerjee: yeast-display library platform.